Gene · 5999
Papers1,442
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,442
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: GPCRs: signal transduction. | Front Mol Biosci | 2024 | 38660374 | PubTator, text mining | PubMed |
| Unraveling the interplay of ferroptosis and immune dysregulation in diabetic kidney disease: a comprehensive molecular analysis. | Diabetol Metab Syndr | 2024 | 38643193 | PubTator, text mining | PubMed |
| Report from the 29th Meeting on Toxinology, "Toxins: From the Wild to the Lab", Organized by the French Society of Toxinology on 30 November-1 December 2023. | Toxins (Basel) | 2024 | 38535813 | PubTator, text mining | PubMed |
| Modulation of Type 5 Metabotropic Glutamate Receptor-Mediated Intracellular Calcium Mobilization by Regulator of G Protein Signaling 4 (RGS4) in Cultured Astrocytes. | Cells | 2024 | 38391904 | PubTator, text mining | PubMed |
| Bioinformatics reveals the pathophysiological relationship between diabetic nephropathy and periodontitis in the context of aging. | Heliyon | 2024 | 38304805 | PubTator, text mining | PubMed |
| CRISPR/Cas9-Mediated Gene Therapy for Glioblastoma: A Scoping Review. | Biomedicines | 2024 | 38275409 | PubTator, text mining | PubMed |
| Identification of novel biomarkers of ferroptosis involved in keloid based on bioinformatics analysis. | Int Wound J | 2024 | 38272797 | PubTator, text mining | PubMed |
| ERK2 Is a Promoter of Cancer Cell Growth and Migration in Colon Adenocarcinoma. | Antioxidants (Basel) | 2024 | 38247543 | PubTator, text mining | PubMed |
| Class VI G protein-coupled receptors in Aspergillus oryzae regulate sclerotia formation through GTPase-activating activity. | Appl Microbiol Biotechnol | 2024 | 38231240 | PubTator, text mining | PubMed |
| Regulators of G-Protein Signaling (RGS) in Sporadic and Colitis-Associated Colorectal Cancer. | Int J Mol Sci | 2024 | 38203748 | PubTator, text mining | PubMed |
| Identification of TFR2 as a novel ferroptosis‑related gene that serves an important role in prognosis and progression of triple‑negative breast cancer. | Oncol Lett | 2024 | 38106522 | PubTator, text mining | PubMed |
| Global Transcriptome Analysis Reveals Distinct Phases of the Endothelial Response to TNF. | J Immunol | 2024 | 38019121 | PubTator, text mining | PubMed |
| Transcriptomic and bioinformatics analysis of the mechanism by which erythropoietin promotes recovery from traumatic brain injury in mice. | Neural Regen Res | 2024 | 37488864 | PubTator, text mining | PubMed |
| Ferroptosis, Metabolic Rewiring, and Endometrial Cancer. | Int J Mol Sci | 2023 | 38203246 | PubTator, text mining | PubMed |
| Decoding signaling mechanisms: unraveling the targets of guanylate cyclase agonists in cardiovascular and digestive diseases. | Front Pharmacol | 2023 | 38186653 | PubTator, text mining | PubMed |
| Effectiveness of pharmacogenomics on the response and remission of treatment-resistant depression: a meta-analysis of randomised controlled trials. | Gen Psychiatr | 2023 | 38155841 | PubTator, text mining | PubMed |
| Unveiling the power of microenvironment in liver regeneration: an in-depth overview. | Front Genet | 2023 | 38152656 | PubTator, text mining | PubMed |
| Histamine Receptors: Ex Vivo Functional Studies Enabling the Discovery of Hits and Pathways. | Membranes (Basel) | 2023 | 38132901 | PubTator, text mining | PubMed |
| Ferroptosis: an important player in the inflammatory response in diabetic nephropathy. | Front Immunol | 2023 | 38111578 | PubTator, text mining | PubMed |
| Ferritinophagy: research advance and clinical significance in cancers. | Cell Death Discov | 2023 | 38110359 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5999/papers?page=3